Knud Andersen

1.9k total citations
31 papers, 1.4k citations indexed

About

Knud Andersen is a scholar working on Cancer Research, Oncology and Genetics. According to data from OpenAlex, Knud Andersen has authored 31 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Cancer Research, 18 papers in Oncology and 8 papers in Genetics. Recurrent topics in Knud Andersen's work include Breast Cancer Treatment Studies (22 papers), Estrogen and related hormone effects (7 papers) and Breast Lesions and Carcinomas (7 papers). Knud Andersen is often cited by papers focused on Breast Cancer Treatment Studies (22 papers), Estrogen and related hormone effects (7 papers) and Breast Lesions and Carcinomas (7 papers). Knud Andersen collaborates with scholars based in Denmark, Belgium and Netherlands. Knud Andersen's co-authors include Henning T. Mouridsen, M Blichert-Toft, Marie Overgaard, Harry Bartelink, Johannes L. Peterse, Richard Sylvester, Geertjan van Tienhoven, Adri C. Voogd, J.A. van Dongen and Carsten Rose and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Surgery and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Knud Andersen

30 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Knud Andersen Denmark 18 1.0k 772 500 289 241 31 1.4k
F May-Levin France 18 699 0.7× 770 1.0× 430 0.9× 153 0.5× 158 0.7× 43 1.3k
Eva S. Singletary United States 20 936 0.9× 545 0.7× 580 1.2× 596 2.1× 121 0.5× 38 1.5k
Susanne Taucher Austria 23 954 0.9× 1.1k 1.4× 456 0.9× 221 0.8× 256 1.1× 45 1.7k
RW Blamey United Kingdom 17 769 0.8× 730 0.9× 273 0.5× 591 2.0× 342 1.4× 36 1.6k
Robert P. Gray United States 15 859 0.8× 718 0.9× 352 0.7× 142 0.5× 174 0.7× 26 1.3k
Alison Estabrook United States 22 1.3k 1.3× 574 0.7× 905 1.8× 823 2.8× 206 0.9× 46 2.1k
Linda de Munck Netherlands 22 947 0.9× 980 1.3× 470 0.9× 366 1.3× 130 0.5× 79 1.6k
Hugh Bishop United Kingdom 6 643 0.6× 524 0.7× 259 0.5× 171 0.6× 265 1.1× 11 1.0k
K.I. Pritchard Canada 15 580 0.6× 682 0.9× 214 0.4× 146 0.5× 183 0.8× 35 1.1k
J. P. Costantino United States 14 801 0.8× 541 0.7× 398 0.8× 194 0.7× 136 0.6× 39 1.1k

Countries citing papers authored by Knud Andersen

Since Specialization
Citations

This map shows the geographic impact of Knud Andersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Knud Andersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Knud Andersen more than expected).

Fields of papers citing papers by Knud Andersen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Knud Andersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Knud Andersen. The network helps show where Knud Andersen may publish in the future.

Co-authorship network of co-authors of Knud Andersen

This figure shows the co-authorship network connecting the top 25 collaborators of Knud Andersen. A scholar is included among the top collaborators of Knud Andersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Knud Andersen. Knud Andersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thomsen, Mette S., Ebbe Laugaard Lorenzen, Jan Alsner, et al.. (2025). Quality assessment of 2705 treatment plans in the randomised Danish Breast Cancer Group Skagen trial 1. Radiotherapy and Oncology. 212. 111142–111142.
2.
Andersen, Knud, Karl Bang Christensen, Henrik Kehlet, & Pernille Envold Bidstrup. (2014). (114) The effect of pain on physical functioning after breast cancer treatment: development and validation of an assessment tool. Journal of Pain. 15(4). S4–S4. 8 indexed citations
3.
Voogd, Adri C., Maja Nielsen, Johannes L. Peterse, et al.. (2001). Differences in Risk Factors for Local and Distant Recurrence After Breast-Conserving Therapy or Mastectomy for Stage I and II Breast Cancer: Pooled Results of Two Large European Randomized Trials. Journal of Clinical Oncology. 19(6). 1688–1697. 423 indexed citations
4.
Tienhoven, Geertjan van, Adri C. Voogd, Johannes L. Peterse, et al.. (1999). Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM). European Journal of Cancer. 35(1). 32–38. 148 indexed citations
5.
Mouridsen, Henning T., Michael Andersson, P Dombernowsky, et al.. (1999). Adjuvant anthracycline in breast cancer. Improved outcome in premenopausal patients following substitution of methotrexate in the CMF Combination with epirubicin. European Journal of Cancer. 35. S83–S83. 48 indexed citations
6.
Blichert-Toft, M, Henning T. Mouridsen, & Knud Andersen. (1998). Clinical trials. Seminars in Surgical Oncology. 12(1). 32–38. 3 indexed citations
7.
Arriagada, R., M Blichert-Toft, Knud Andersen, et al.. (1998). When is survival a cure in early stage breast cancer? twenty-year follow-up from 3 randomized trials. International Journal of Radiation Oncology*Biology*Physics. 42(1). 182–182. 2 indexed citations
8.
Hansen, Per Syrak, et al.. (1997). Quality Control of End Results in a Danish Adjuvant Breast Cancer Multi-Center Study. Acta Oncologica. 36(7). 711–714. 16 indexed citations
9.
Wohlfahrt, Jan, et al.. (1997). Time since childbirth and prognosis in primary breast cancer: population based study. BMJ. 315(7112). 851–855. 76 indexed citations
10.
Andreasen, A. H. M., et al.. (1994). [Mammographic examinations in Denmark, 1990-1991].. PubMed. 156(44). 6517–20. 6 indexed citations
11.
Overgaard, Marie, H Johansen, Carsten Rose, et al.. (1990). Evaluation of radiotherapy in high-risk breast cancer patients: Report from the Danish Breast Cancer Cooperative Group (DBCG 82) trial. International Journal of Radiation Oncology*Biology*Physics. 19(5). 1121–1124. 96 indexed citations
12.
Kamby, Claus, Carsten Rose, Bent Ejlertsen, et al.. (1988). Adjuvant systemic treatment and the pattern of recurrences in patients with breast cancer. European Journal of Cancer and Clinical Oncology. 24(3). 439–447. 14 indexed citations
13.
Andersen, Knud & Henning T. Mouridsen. (1988). Danish Breast Cancer Cooperative Group (DBCG): A description of the register of the nation-wide programme for primary breast cancer. Acta Oncologica. 27(6). 627–647. 105 indexed citations
14.
Overgaard, Marie, H Johansen, H Brincker, et al.. (1988). Postmastectomy Irradiation in High-Risk Breast Cancer Patients: Present status of the Danish Breast Cancer Cooperative Group trials. Acta Oncologica. 27(6). 707–714. 50 indexed citations
15.
Dombernowsky, P, H Brincker, Morten Hansen, et al.. (1988). Adjuvant Therapy of Premenopausal and Menopausal High-Risk Breast Cancer Patients: Present status of the Danish Breast Cancer Cooperative Group Trials 77-B and 82-B. Acta Oncologica. 27(6). 691–697. 39 indexed citations
16.
Thomsen, Henrik S., et al.. (1987). Bone metastases in primary operable breast cancer. The role of a yearly scintigraphy. European Journal of Cancer and Clinical Oncology. 23(6). 779–781. 11 indexed citations
17.
Kamby, Claus, Carsten Rose, Bent Ejlertsen, et al.. (1987). Stage and pattern of metastases in patients with breast cancer. European Journal of Cancer and Clinical Oncology. 23(12). 1925–1934. 32 indexed citations
18.
Andersen, Johan A., et al.. (1984). Prognostic significance of residual cancer tissue after diagnostic biopsy in breast carcinoma. Three-year short-term results. European Journal of Cancer and Clinical Oncology. 20(6). 765–770. 8 indexed citations
19.
Rose, Carsten, Susan M. Thorpe, Henning T. Mouridsen, et al.. (1983). Antiestrogen treatment of postmenopausal women with primary high risk breast cancer. Breast Cancer Research and Treatment. 3(1). 77–84. 27 indexed citations
20.
Rossing, Niels Nygaard, et al.. (1982). What do early bone scans tell about breast cancer patients?. European Journal of Cancer and Clinical Oncology. 18(7). 629–636. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F May-Levin Breakdown of academic impact, for papers by Eva S. Singletary Breakdown of academic impact, for papers by Susanne Taucher Breakdown of academic impact, for papers by RW Blamey Breakdown of academic impact, for papers by Robert P. Gray Breakdown of academic impact, for papers by Alison Estabrook Breakdown of academic impact, for papers by Linda de Munck Breakdown of academic impact, for papers by Hugh Bishop Breakdown of academic impact, for papers by K.I. Pritchard Breakdown of academic impact, for papers by J. P. Costantino
Rankless by CCL
2026